Get started
Author

Manuela Balocco

Observed names: Balocco, Balocco, M, M Balocco, M. Balocco
ORCID: 0009-0008-9308-1722
Observed ORCID: 0009-0008-9308-1722
OpenAlex ID: A5067079961
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation
2011 · G. Abbruzzese, G. Cossu, et al. · Haematologica · 134
PDF
Sickle cell disease: a review for the internist
2019 · Valeria Maria Pinto, Manuela Balocco, et al. · Internal and Emergency Medicine · 114
Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up
2014 · Giovanni Cossu, Giovanni Abbruzzese, et al. · Parkinsonism & Related Disorders · 93
Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation
2008 · Gian Luca Forni, Manuela Balocco, et al. · Movement Disorders · 81
Luspatercept for the treatment of anaemia in non-transfusion-dependent β-thalassaemia (BEYOND): a phase 2, randomised, double-blind, multicentre, placebo-controlled trial
2022 · Ali T Taher, Maria Domenica Cappellini, et al. · The Lancet Haematology · 75
SARS‐CoV ‐2 infection in beta thalassemia: Preliminary data from the Italian experience
2020 · Irene Motta, Margherita Migone De Amicis, et al. · American Journal of Hematology · 62
PDF
Changes in the quality of life of people with thalassemia major between 2001 and 2009
2013 · Massimo Costantini, Gollo, et al. · Patient Preference and Adherence · 53
PDF
Adding low‐dose gemtuzumab ozogamicin to fludarabine, Ara‐C and idarubicin (MY‐FLAI) may improve disease‐free and overall survival in elderly patients with non‐M3 acute myeloid leukaemia: results of a prospective, pilot, multi‐centre trial and comparison with a historical cohort of patients
2007 · Marino Clavio, Luana Vignolo, et al. · British Journal of Haematology · 40
Daily alternating deferasirox and deferiprone therapy for “hard‐to‐chelate” β‐thalassemia major patients
2010 · Manuela Balocco, Paola Carrara, et al. · American Journal of Hematology · 38
The influence of treatment in specialized centers on survival of patients with thalassemia major
2009 · Gian Luca Forni, Matteo Puntoni, et al. · American Journal of Hematology · 37
PDF
Trichosporon asahii infection treated with caspofungin combined with liposomal amphotericin B
2004 · M. Bassetti, Francesca Bisio, et al. · Journal of Antimicrobial Chemotherapy · 31
Musculoskeletal Manifestations of Chronic Anemias
2011 · Carlo Martinoli, Lorenzo Bacigalupo, et al. · Seminars in Musculoskeletal Radiology · 29
Diagnostic value of real-time elastography in the assessment of hepatic fibrosis in patients with liver iron overload
2013 · Francesco Paparo, Luca Cevasco, et al. · European Journal of Radiology · 28
Combination of liposomal daunorubicin (DaunoXome), fludarabine, and cytarabine (FLAD) in patients with poor-risk acute leukemia
2004 · Marino Clavio, Claudia Venturino, et al. · Annals of Hematology · 26
Lack of correlation between heart, liver and pancreas MRI ‐ R 2*: Results from long‐term follow‐up in a cohort of adult β‐thalassemia major patients
2017 · Valeria Maria Pinto, Lorenzo Bacigalupo, et al. · American Journal of Hematology · 22
PDF
Development of interactive algorithm for clinical management of acute events related to sickle cell disease in emergency department
2014 · Gian Luca Forni, Gabriele Finco, et al. · Orphanet Journal of Rare Diseases · 22
PDF
Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter study
2011 · G. Derchi, F. Formisano, et al. · European Journal of Echocardiography · 22
Development of Algorithm for Clinical Management of Sickle Cell Bone Disease: Evidence for a Role of Vertebral Fractures in Patient Follow-up
2020 · Lucia De Franceschi, Daniele Gabbiani, et al. · Journal of Clinical Medicine · 20
PDF
Measurement of liver iron overload: Noninvasive calibration of MRI‐R2* by magnetic iron detector susceptometer
2011 · B. Gianesin, D. Zefiro, et al. · Magnetic Resonance in Medicine · 20
PDF
Efficacy and safety of sildenafil for the treatment of severe pulmonary hypertension in patients with hemoglobinopathies: results from a long-term follow up
2014 · G. Derchi, M. Balocco, et al. · Haematologica · 16
PDF
Differential effects of the type of iron chelator on the absolute number of hematopoietic peripheral progenitors in patients with -thalassemia major
2012 · G. L. Forni, M. Podesta, et al. · Haematologica · 16
PDF
Italian patients with hemoglobinopathies exhibit a 5‐fold increase in age‐standardized lethality due to SARS‐CoV‐2 infection
2021 · Filomena Longo, Barbara Gianesin, et al. · American Journal of Hematology · 15
PDF
Total Iron-Overload Measurement in the Human Liver Region by the Magnetic Iron Detector
2010 · M Marinelli, B Gianesin, et al. · IEEE Transactions on Biomedical Engineering · 13
A Phase II Trial of FM (Oral Fludarabine and Mitoxantrone) Chemotherapy Followed by Yttrium 90 (90Y) Ibritumomab Tiuxetan (Zevalin®) for Previously Untreated Follicular Lymphoma (FL) Patients.
2006 · Pier Luigi Zinzani, Alessandro Pulsoni, et al. · Blood · 11
Ifosfamide, epirubicin, etoposide (IEV) and autologous peripheral blood progenitor cell transplant: A feasible and effective salvage treatment for lymphoid malignancies
2005 · Marino Clavio, Alberto Garrone, et al. · Oncology Reports · 11
Works count: 50
Citation count: 1,116
H-index: 19
I10-index: 27
Year
Topic
Type